Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2025-12-25 @ 2:31 PM
NCT ID:
NCT04424966
Group ID:
EG000
Title:
Recurrent High Grade Glioma
Description:
Participants with recurrent high grade glioma with FGFR1 K656E mutation, or FGFR3 K650E mutation, or FGFR3-TACC3 translocation who are scheduled for surgical resection.
125 mg of infigratinib will be administered orally for 7 days prior to surgical resection during the Phase 0 component. Participants with tumors demonstrating positive PK response will continue treatment in the expansion phase component.
125 mg of infigratinib will be administered orally for 21 consecutive days during 28-day treatment cycles during the expansion phase component.
Deaths Number Affected:
6
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
7
Other Number Affected:
5
Other Number At Risk:
7
Study:
NCT04424966
Results Section:
NCT04424966
Adverse Events Module:
NCT04424966